Patent Law Weblog
recent posts
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
- BioNTech Sues Moderna over mRNA Vaccine Technology
- CNIPA Issues Letter on Identity of Foreign Inventors
about
Month: July 2011
-
The Institute for International Research (IIR) will be holding its 3rd Annual Business of Biosimilars & Biobetters conference from September 19-21, 2011 in Boston, MA. The conference will allow attendees to: • Understand the regulatory and legal implications that may affect your biosimilar profitability;• Create strategies to ensure commercialization success;• Leverage new manufacturing processes to…
-
American Conference Institute (ACI) will be holding its Boston edition of its Life Sciences Business Development & Acquisitions in Emerging Markets conference on September 26-27, 2011 in New York, NY. ACI faculty will help attendees: • Implement strategies that provide commercial entry into lucrative emerging markets;• Replenish product pipelines via partnering and co-promotions;• Weigh when…
-
By James DeGiulio — Drug Wholesalers Secure Injunction Blocking Braintree from Terminating MiraLAX Supply Direct purchasers of MiraLAX, who have brought a class action suit headed by Rochester Drug Cooperative ("RDC") against drugmaker Braintree Laboratories Inc., were successful in obtaining a preliminary injunction blocking Braintree from terminating its sales to the drug wholesaler plaintiffs. In…
-
By Kwame Mensah — Recently, MultiCell Technologies, Inc. of Woonsocket, RI, a clinical-stage biopharmaceutical company focusing on unmet medical needs for the treatment of neurological disorders, hepatic disease, and cancer, announced that it had been issued U.S. Patent No. 7,935,528, which is related to the isolation and use of human liver stem cells to treat…
-
By James DeGiulio — The Food and Drug Administration has been the subject of recent criticism from drugmaker advocates who allege that the FDA's tougher safety standards have slowed down the pace of drug approvals and have hurt the drug industry. However, despite these allegedly repressive safety standards, the head of the FDA's drug division,…
-
By Kwame Mensah — Last month's BIO International Conference kicked off on June 27th with a presentation entitled "IP Issues Affecting Biomarker-Based Diagnostics." The four panelists for the session were David Gass of Marshall, Gerstein & Borun, LLP; Dr. Thorlakur Jonsson, the Director of Intellectual Property at deCODE genetics ehf; Dr. Simon O'Brien of D.…
-
By Donald Zuhn — Reports Suggest Senate Action on Patent Reform Bill Could Be Weeks Away In Monday's IPO Daily News, the Intellectual Property Owners Association (IPO) suggested that H.R. 1249, which the House passed on June 23 (see "House Passes H.R. 1249"), might not be brought up by the Senate until after Congress' August…
-
By Donald Zuhn — Last week, in Reckitt Benckiser Inc. v. Watson Laboratories, Inc. – Florida, the Federal Circuit affirmed a decision by the District Court for the Southern District of Florida holding that Defendant-Appellee Watson Laboratories, Inc. – Florida did not infringe the asserted claims of U.S. Patent No. 6,372,252. The Federal Circuit also…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Ferring B.V. v. Watson Pharmaceuticals, Inc. et al.3:11-cv-00481; filed July 7, 2011 in the District Court of Nevada • Plaintiff: Ferring B.V.• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Laboratories, Inc. – Florida; Watson…
-
July 16-19, 2011 – 2011 Annual Meeting; The Nuts & Bolts of Patent Prosecution Practice; and 2011 Patent Practice Update (National Association of Patent Practitioners) – Las Vegas, NV July 18-19, 2011 – Hatch-Waxman Boot Camp*** (American Conference Institute) – San Diego, CA July 20-21, 2011 – Advanced Forum on Life Sciences Collaborative Agreements and…
Patent Docs 